# OnCo record enara-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/enara-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "enara-bio" ;
  schema:name "Enara Bio"@en ;
  schema:alternateName "Enara Bio Limited"@en ;
  schema:description "An Oxford company that looks for cancer-only markers hidden in parts of the genome usually ignored, and builds drugs that steer the immune system's T cells onto tumours carrying them. Its lead drug, ENA101, is still in laboratory testing for several solid tumours."@en ;
  schema:url <https://onco.cc/companies/enara-bio/>, <https://enarabio.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://enarabio.com/>, <https://enarabio.com/pipeline>, <https://enarabio.com/about>, <https://enarabio.com/news/aacr2026>, <https://find-and-update.company-information.service.gov.uk/company/10469748>, <https://www.racap.com/portfolio/enara-bio> ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> .